Prachi Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 2.00 Cr
as on 16-11-2024
- Company Age 37 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 69.30 Cr
as on 16-11-2024
- Satisfied Charges ₹ 29.56 Cr
as on 16-11-2024
- Revenue 8.21%
(FY 2023)
- Profit 33.04%
(FY 2023)
- Ebitda 25.29%
(FY 2023)
- Net Worth 28.12%
(FY 2023)
- Total Assets 29.77%
(FY 2023)
About Prachi Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 2.00 Cr.
The company currently has active open charges totaling ₹69.30 Cr. The company has closed loans amounting to ₹29.56 Cr, as per Ministry of Corporate Affairs (MCA) records.
Pankaj Shah and Chintan Shah serve as directors at the Company.
- CIN/LLPIN
U24230MH1987PTC044050
- Company No.
044050
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Jul 1987
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Prachi Pharmaceuticals Private Limited offer?
Prachi Pharmaceuticals Private Limited offers a wide range of products and services, including Chemical Reagents & Catalysts, Iodine Compounds, Potassium Salts, Hand Sanitizers & Personal Hygiene, Antiseptic Liquid & Cream, Pharma Ingredients & Raw Materials, API Intermediate, Cardiovascular Drugs & Medication, Diabetes Medicine, Industrial Chemicals & Supplies.
Who are the key members and board of directors at Prachi Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pankaj Shah  | Director | 13-Jul-1987 | Current |
| Chintan Shah | Director | 10-Mar-2008 | Current |
Financial Performance of Prachi Pharmaceuticals.
Prachi Pharmaceuticals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 8.21% increase. The company also saw a substantial improvement in profitability, with a 33.04% increase in profit. The company's net worth Soared by an impressive increase of 28.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Prachi Pharmaceuticals?
In 2023, Prachi Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Standard Chartered Bank Creation Date: 24 Mar 2022 | ₹9.50 Cr | Open |
Standard Chartered Bank Creation Date: 28 Sep 2021 | ₹9.50 Cr | Open |
Standard Chartered Bank Creation Date: 28 Sep 2021 | ₹5.00 M | Open |
How Many Employees Work at Prachi Pharmaceuticals?
Prachi Pharmaceuticals has a workforce of 30 employees as of Oct 18, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Prachi Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prachi Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
